Biogen revenue, profit beat Street on strong Spinraza launch

Biogen Inc reported quarterly revenue and profit that beat analysts’ estimates, boosted by strong sales of recently launched spinal muscular atrophy drug Spinraza.

Sourced through Scoop.it from: www.reuters.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s